ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,070.80
-0.05%
다우존스 지수
40,003.59
0.34%
Bitcoin
66,787.05
2.37%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Veracyte Inc (VCYT)

  7. Veracyte Inc (VCYT) 뉴스

VCYT Veracyte Inc

22.73
-0.67 (-2.86%)
시간외 거래
최종 업데이트: 06:30:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Veracyte Inc VCYT 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.67 -2.86% 22.73 06:30:00
개장가 저가 고가 종가 전일 종가
23.44 22.85 23.47 22.88 23.40
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
16/05/202406:04BWVeracyte to Participate in Upcoming Investor Conferences
09/05/202406:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/05/202405:10EDGAR2Form 8-K - Current report
08/05/202405:05BWVeracyte Announces First Quarter 2024 Financial Results
07/05/202405:05BW14 Studies Presented at AUA 2024 Show Decipher Tests’..
23/04/202406:00BWVeracyte to Release First Quarter 2024 Financial Results on..
22/04/202421:30BWNew Study Shows Veracyte’s Decipher Prostate Test is..
16/04/202421:30BWVeracyte Announces that Nine Studies Reinforcing the Value..
09/03/202406:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202406:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202406:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202406:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202406:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202406:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202407:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202407:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202407:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202407:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202407:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202407:27EDGAR2Form 8-K - Current report
01/03/202407:22EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
01/03/202407:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
01/03/202406:40EDGAR2Form S-3ASR - Automatic shelf registration statement of..
29/02/202422:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/02/202407:55BWVeracyte’s Decipher Prostate Test Receives Highest..
23/02/202406:12EDGAR2Form 8-K - Current report
23/02/202406:05BWVeracyte Announces Fourth Quarter and Full-Year 2023..
22/02/202407:00BWVeracyte to Participate in the Raymond James 45th Annual..
14/02/202406:15EDGAR2Form 8-K - Current report
08/02/202422:00BWVeracyte to Release Fourth Quarter and Full-Year 2023..
06/02/202422:23EDGAR2Form 8-K - Current report
06/02/202422:15BWVeracyte Completes Acquisition of C2i Genomics
30/01/202406:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/01/202422:12EDGAR2Form 8-K - Current report
08/01/202422:00BWVeracyte Announces Preliminary Full-Year 2023 Results,..
13/12/202306:30BWVeracyte to Participate in the 42nd Annual J.P. Morgan..
06/12/202306:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202306:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202306:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202306:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202306:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202306:05BWReal-World Data Presented at SUO 2023 Show that Veracyte’s..
29/11/202322:30BWClinical Validation Data Published in CHEST Demonstrate that..
22/11/202322:30BWVeracyte Announces Seven Posters Highlighting Clinical Value..
08/11/202322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202306:09EDGAR2Form 8-K - Current report
08/11/202306:05BWVeracyte Announces Third Quarter 2023 Financial Results
08/11/202306:00BWVeracyte Announces In Vitro Diagnostic Agreement with..
02/11/202321:15BWVeracyte to Participate in the Stephens Annual Investment..
27/10/202321:30BWVeracyte Announces SITC 2023 Presentations Offering New..

최근 히스토리

NASDAQ
VCYT
Veracyte
TSX
FCUL
Fidelity US Low Volatili...
LSE
STG
Strip Tinning
USOTC
ACCLF
Accel Solutions (GM)
GATE
BTCBEARUSDT
3X Short Bitcoin Token
BSTP
INJEUR
Injective Token
TSXV
CKB
Calico Resources Corp.
BIT
3LMI
Graniteshares 3x Long Mi...
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유